Post-Marketing Surveillance of a generic Oxaliplatin (AlvoxalⓇ) in Iranian Patients with Cancer
ABSTRACT: Background: CRC is the second and third most common cancer in women and men, respectively. The national comprehensive cancer network guidelines recommend oxaliplatin-based chemotherapy as a preferred regimen for patients with advanced or metastatic colon cancer. Oxaliplatin is also used i...
Full description
Bibliographic Details
| Main Authors: |
Farhad Shahi,
Mojtaba Gorji, Assistant Professor of Pediatric Oncology,
Mehrdad Payandeh, Assistant Professor of Hematology & Oncology,
Hamid Rezvani, Associate Professor of Hematology & Oncology,
Mohammad Vaezi, Associate Professor of Hematology & Oncology,
Sharareh Seifi, Assistant Professor of Hematology & Oncology,
Alireza Baari, Post doctoral fellowship,
Reza Khalili-Dizaji, Post doctoral fellowship,
Seyed Mehdi Hashemi, Associate Professor of Hematology & Oncology,
Saeid Salimi, post doctoral fellowship,
Hosein Kamranzadeh, Associate Professor of Hematology & Oncology,
Babak Shazad, Post doctoral fellowship,
Sina Salari, Associate Professor of Hematology & Oncology,
Davoud Oulad Dameshghi, Assistant Professor of Hematology & Oncology,
Mehdi Sarkheil, Post doctoral fellowship,
Mehrzad Mirzania, Associate Professor of Hematology & Oncology,
Nassim Anjidani, Pharm. D. |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Elsevier
2022-01-01
|
|---|
| Series: | Current Therapeutic Research
|
|---|
| Subjects: | |
|---|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X21000357
|
|---|